StonvexLoading…
StonvexStonvexStonvexCore line items from EMBC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $1.08B | $1.12B | $1.12B | $1.13B |
Operating Income | $242.10M | $166.80M | $221.50M | $309.60M |
Net Income | $95.40M | $78.30M | $70.40M | $223.60M |
EPS (Diluted) | $1.62 | $1.34 | $1.22 | $3.89 |
Total Assets | $1.09B | $1.29B | $1.21B | $1.09B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $225.50M | $267.50M | $326.30M | $330.90M |
Free Cash Flow OCF − CapEx | $182.40M | $19.90M | $41.20M | $388.60M |
Shares Outstanding | 58.50M | 57.71M | 57.33M | 57.06M |